Study title:
Usefulness of Tc-99m HMPAO-labeled WBC heart scan to predict
impaired ventricular function and coronary artery dilation in children with Kawasaki diseaseHsiu-Bao Hsua, Yun-Ching Fub,c,*, Shih-Chuan Tsaid, Ruoh-Fang Yene, Betau Hwangc,f. International Journal of Cardiology 92 (2003) 65– 69
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Diagnosis
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: CERETEC |
ATC code: |
Document link:
hsiu-bao h 2003.pdf
|
Document date: 2014-11-18
|
Study number: |
EudraCT number:
|
Scope of study: CLINICAL |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
-
|
-
|